238 results on '"Dorostkar, Mario M."'
Search Results
2. Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
3. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation
4. Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration
5. Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO)
6. Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
7. Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
8. Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers
9. Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas
10. Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations
11. Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes.
12. Early defects in translation elongation factor 1α levels at excitatory synapses in α-synucleinopathy
13. Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
14. Molecular refinement of pilocytic astrocytoma in adult patients.
15. Correction to: Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations
16. Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
17. A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors
18. The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine
19. Amyloid precursor protein maintains constitutive and adaptive plasticity of dendritic spines in adult brain by regulating D‐serine homeostasis
20. Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease
21. Analyzing dendritic spine pathology in Alzheimer’s disease: problems and opportunities
22. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer’s disease
23. HGG-45. Characterization of spinal diffuse midline gliomas, H3 K28M-mutant
24. EPEN-27. Epigenetic dissection of spinal ependymomas (SP-EPN) separates tumors with and withoutNF2 mutation
25. Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease
26. Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition
27. Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas
28. Molecular Tumor Board Case Report: Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma
29. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors
30. Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
31. PATH-32. EXTENT, PATTERN, AND PROGNOSTIC VALUE OF MGMT PROMOTOR METHYLATION: DOES IT DIFFER BETWEEN GLIOBLASTOMA AND IDH-WILDTYPE/TERT-MUTATED ASTROCYTOMA?
32. PATH-34. MOLECULAR AND CLINICAL HETEROGENEITY WITHIN SPINAL EPENDYMOMAS
33. δ Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine
34. Ausmaß und prognostische Relevanz der MGMT Promotor Methylierung unterscheidet sich nicht zwischen Glioblastomen und IDH-Wildtyp TERT mutierten Astrozytomen
35. Infiltration der subventrikulären Zone ist mit schlechterem Outcome in Gliomen WHO Grad II assoziiert
36. Additional file 1 of Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas
37. Amyloid plaque formation precedes dendritic spine loss
38. In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks
39. Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer’s disease mouse model
40. Pre-therapeutic Microglia Activation and Sex Determine Therapy Effects of Chronic Immunomodulation
41. Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition
42. The brain-specific double-stranded RNA-binding protein Staufen2 is required for dendritic spine morphogenesis
43. Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine
44. BIOM-15. SUBVENTRICULAR ZONE INVOLVEMENT IS ASSOCIATED WITH WORSE OUTCOME IN GLIOMA WHO GRADE II INDEPENDENT OF MOLECULAR MARKERS
45. PATH-28. EXTENT AND PROGNOSTIC VALUE OF MGMT PROMOTOR METHYLATION DEPEND ON IDH MUTATION AND 1p19q CO-DELETION IN GLIOMA WHO GRADE II
46. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors.
47. Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma.
48. Early and longitudinal microglial activation but not amyloid accumulation predict cognitive outcome in PS2APP mice
49. Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses
50. Serotonin-transporter mediated efflux: A pharmacological analysis of amphetamines and non-amphetamines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.